Lungs News and Research

RSS

Specific lung cell exhibits immune properties and improves respiratory viral disease outcomes

Researchers at Children's Hospital of Philadelphia have discovered that a specific type of lung cell exhibits unconventional immune properties and may contribute to the outcome of respiratory viral infections.

28 Jun 2021

Researchers determine molecular structure of bacterial protein complex critical for tuberculosis

Tuberculosis is one of the top ten causes of death worldwide, infecting about one-quarter of the world's population. Although it is treatable, the rise of multidrug-resistant tuberculosis poses a major threat to global health security, and has been declared by the World Health Organization as a global health emergency.

25 Jun 2021

New artificial intelligence system could lead to improved ways to control high ozone problems

Ozone levels in the earth's troposphere (the lowest level of our atmosphere) can now be forecasted with accuracy up to two weeks in advance, a remarkable improvement over current systems that can accurately predict ozone levels only three days ahead.

25 Jun 2021

Researchers decode humans’ survival from historical coronavirus outbreaks

An international team of researchers co-led by the University of Adelaide and the University of Arizona has analyzed the genomes of more than 2,500 modern humans from 26 worldwide populations, to better understand how humans have adapted to historical coronavirus outbreaks.

25 Jun 2021

Scientists identify new virulence mechanism for a surface protein on pneumonia-causing bacteria

A bout with flu virus can be hard, but when Streptococcus pneumonia enters the mix, it can turn deadly.

24 Jun 2021

Study finds no evidence for remdesivir's benefit in severe COVID-19 patients

A new analysis of current data indicates that remdesivir does not show efficacy in regulating the severity of the illness.

23 Jun 2021

SARS-CoV-2 infection and transmission in the North American deer mouse

A recent study conducted in Canada reports that the North American deer mouse can be infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from humans.

23 Jun 2021

Natural compound myricetin shows antiviral potential against SARS-CoV-2

New findings from a team of Chinese researchers suggest natural compounds — specifically the flavonoid myricetin — could also be a potential drug candidate for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

23 Jun 2021

At Texas border, pandemic’s high toll lays bare gaps in health and insurance

Alfredo "Freddy" Valles was an accomplished trumpeter and a beloved music teacher for nearly four decades at one of the city's poorest middle schools.

23 Jun 2021

Study provides treatment guidance for children and adolescents with multisystem inflammatory syndrome

An analysis conducted by a group of investigators including Tamara Bradford, MD, Associate Professor of Pediatrics at LSU Health New Orleans School of Medicine, found that children and adolescents with Multisystem inflammatory syndrome in children (MIS-C) initially treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone.

22 Jun 2021

Albumin supplementation improves human fertility, fights infection

A new University of California, Irvine-led study reveals albumin (Alb), among the most abundant proteins in the body, activates a proton channel (hHv1), also widespread in the body, giving sperm the ability to penetrate and fertilize an egg, and allowing white blood cells to secrete large amounts of inflammatory mediators to fight infection.

22 Jun 2021

Combination of SFRP2 and PD-1 immunotherapy halts aggressive metastatic cancer in preclinical model

In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist Nancy Klauber-DeMore, M.D., is pioneering new discoveries.

22 Jun 2021

Dual-antibody combination therapies effective against SARS-CoV-2 variants in animal study

COVID-19 therapies made from antibodies often are given to patients who are at high risk of severe illness and hospitalization. However, there have been nagging questions about whether such antibody therapies retain their effectiveness as worrisome new virus variants arise.

21 Jun 2021

Upper airway model derived from iPSCs paves the way for broader studies of viral lung infections

A team led by researchers at Newcastle University, UK has successfully created a model of the cells found in the lungs that can be used to replicate how COVID-19 infects the airways.

21 Jun 2021

New method accurately detects virulent infections in advance

When viruses infect cells, changes in the cell nucleus occur, and these can be observed through fluorescence microscopy.

21 Jun 2021

Anti-coronavirus molecules from microbes could be key to new treatments

Microbes in the gut that produce beneficial compounds could hold the key to treating coronavirus symptoms.

21 Jun 2021

Targeting lung inflammation with cell membrane-based dexamethasone nanodelivery platform

Recently, researchers discuss their development of cell membrane-based nanoparticles that successfully delivered dexamethasone directly to inflamed lung cells.

21 Jun 2021

Combination of doxycycline and TB drug treatment reduces the size of lung cavities

Globally, an estimated 10 million people develop tuberculosis (TB) each year and the disease remains a leading cause of death from a single infectious agent. Standard short-course anti-TB treatment still requires a regimen of at least six months of antimicrobial drugs, and drug-resistant TB is an increasing public health threat.

21 Jun 2021

Researchers describe a new science-based intervention for hiccups

Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and colleagues worldwide describe a new science-based intervention for hiccups in a research letter published June 18 in the journal JAMA Network Open.

21 Jun 2021

Commensal bacteria in the human intestine produce compounds that inhibit SARS-CoV-2

Researchers from Yonsei University in South Korea have found that certain commensal bacteria that reside in the human intestine produce compounds that inhibit SARS-CoV-2.

21 Jun 2021

Lungs News and Research

Specific lung cell exhibits immune properties and improves respiratory viral disease outcomes

Researchers determine molecular structure of bacterial protein complex critical for tuberculosis

New artificial intelligence system could lead to improved ways to control high ozone problems

Researchers decode humans’ survival from historical coronavirus outbreaks

Scientists identify new virulence mechanism for a surface protein on pneumonia-causing bacteria

Study finds no evidence for remdesivir's benefit in severe COVID-19 patients

SARS-CoV-2 infection and transmission in the North American deer mouse

Natural compound myricetin shows antiviral potential against SARS-CoV-2

At Texas border, pandemic’s high toll lays bare gaps in health and insurance

Study provides treatment guidance for children and adolescents with multisystem inflammatory syndrome

Albumin supplementation improves human fertility, fights infection

Combination of SFRP2 and PD-1 immunotherapy halts aggressive metastatic cancer in preclinical model

Dual-antibody combination therapies effective against SARS-CoV-2 variants in animal study

Upper airway model derived from iPSCs paves the way for broader studies of viral lung infections

New method accurately detects virulent infections in advance

Anti-coronavirus molecules from microbes could be key to new treatments

Targeting lung inflammation with cell membrane-based dexamethasone nanodelivery platform

Combination of doxycycline and TB drug treatment reduces the size of lung cavities

Researchers describe a new science-based intervention for hiccups

Commensal bacteria in the human intestine produce compounds that inhibit SARS-CoV-2

The ultimate guide to lung research tools and protocols eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News